Neomile Asset Managers Pvt. Ltd. has disclosed a reduction in its stake in Anlon Healthcare Limited through open market transactions conducted by its investment fund. The disclosure was filed in compliance with Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Transaction Details

Neomile Growth Fund – Series I, managed by Neomile Asset Managers, disposed of 4,07,255 shares in Anlon Healthcare Limited through open market sales. The transactions were executed between March 8-10, 2026, representing 0.76% of the company's total share capital.

Shareholding Changes

The sale resulted in a reduction of Neomile's stake in Anlon Healthcare from 5.16% to 4.40%. The fund's shareholding decreased from 27,45,296 shares to 23,38,041 shares following the disposal.

Company Information

Anlon Healthcare Limited's shares are listed on both the National Stock Exchange of India Limited (NSE) and Bombay Stock Exchange Limited (BSE). The company's equity share capital remained unchanged at 5,31,51,500 shares throughout the transaction period. Neomile Growth Fund – Series I is not part of the promoter or promoter group of Anlon Healthcare.

Regulatory Compliance

The disclosure was signed by CA Rashesh Shah, Director of Neomile Asset Managers Pvt. Ltd., and filed with both stock exchanges and the target company on March 11, 2026. The fund holds PAN number AAETN3197R and operates from Mumbai. The transaction involved only equity shares carrying voting rights, with no encumbrances, warrants, or convertible securities involved in the disposal.

Anlon Healthcare Limited has announced a comprehensive postal ballot seeking shareholder approval for several significant corporate actions, including a stock split, authorized capital increase, and bonus share issue. The company has set the remote e-voting period from March 10, 2026 to April 08, 2026, with March 06, 2026 as the cut-off date for eligible shareholders.

Stock Split Proposal

The company proposes to subdivide every 1 equity share having face value of Rs.10 into 5 equity shares of Rs.2 each. This stock split aims to enhance liquidity in the company's equity shares and encourage greater participation by retail investors and small potential investors.

Authorized Capital Increase

Following the stock split, the company seeks to double its authorized share capital from Rs.55,00,00,000 to Rs.1,10,00,00,000 by creating additional 27,50,00,000 equity shares of Rs.2 each. This increase will facilitate the proposed bonus issue and provide flexibility for future capital requirements.

Bonus Share Issue

The Board of Directors has recommended issuing bonus shares in the ratio of 1:1, meaning shareholders will receive 1 new fully paid-up equity share of Rs.2 for every 1 existing share held. The bonus issue will be funded by capitalizing up to Rs.53,15,15,000 from the company's securities premium and/or free reserves.

E-Voting Process and Timeline

The postal ballot will be conducted entirely through remote e-voting, with no physical ballot forms being distributed. Shareholders can cast their votes through the e-voting platform provided by KFin Technologies Limited.

Corporate Governance and Compliance

M/s. K.P. Ghelani and Associates, Company Secretary in Practice, has been appointed as the Scrutinizer to conduct the postal ballot process in a fair and transparent manner. The company confirms compliance with all regulatory requirements under the Companies Act, 2013, and SEBI regulations.

The Board of Directors approved these proposals at their meeting held on March 06, 2026, recommending them as being in the best interest of shareholders. The company has confirmed that it has not defaulted on any statutory payments including employee dues, fixed deposits, or debt securities.

Rationale and Benefits

According to the explanatory statement, these corporate actions reflect the company's strong financial position and positive growth outlook. The stock split is expected to make shares more affordable for retail investors, while the bonus issue rewards existing shareholders and demonstrates confidence in the company's future prospects. Anlon Healthcare was incorporated in 2013 and got listed on BSE and NSE in 2025, showing consistent growth in business operations and financial performance.